Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00518596Phase 2Completed

Prevention of Infection in Indian Neonates - Phase II Probiotics Study

Role: collaborator

NCT00518609Completed

Prevention of Infection in Indian Neonates - Phase I Observational Study

Role: collaborator

NCT01508507Unknown

Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine

Role: collaborator

NCT01365442Completed

Pilot Introduction of Oral Cholera Vaccine in Orissa, India

Role: collaborator

All 4 trials loaded